|
|
See Category: Diseases of the respiratory system
See Header: Severe persistent asthma
ICD-10 (CM) Code and Descriptor
|
J45.50 |
Severe persistent asthma, uncomplicated
|
J4550 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 73.60%
|
10.84%
|
4.80%
|
3.12%
|
2.13%
|
1.40%
|
1.11%
|
0.79%
|
0.58%
|
0.45%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for J45.50*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
63,265
|
83,226
|
|
J2357
|
OMALIZUMAB INJECTION |
44,752
|
1,987,738
|
|
J2182
|
INJECTION, MEPOLIZUMAB, 1MG |
20,017
|
2,014,250
|
|
J0517
|
INJ., BENRALIZUMAB, 1 MG |
11,324
|
334,778
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
9,881
|
9,906
|
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
4,799
|
5,777
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,447
|
3,453
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2,699
|
2,700
|
|
86003
|
ALLG SPEC IGE CRUDE XTRC EA |
1,967
|
19,388
|
|
J2786
|
INJECTION, RESLIZUMAB, 1MG |
1,921
|
386,903
|
|
82785
|
ASSAY OF IGE |
1,859
|
2,099
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
1,727
|
1,738
|
|
94060
|
EVALUATION OF WHEEZING |
1,703
|
1,704
|
|
94729
|
CO/MEMBANE DIFFUSE CAPACITY |
1,574
|
1,574
|
|
G0239
|
OTH RESP PROC, GROUP |
1,353
|
1,363
|
|
94010
|
BREATHING CAPACITY TEST |
1,255
|
1,256
|
|
94726
|
PULM FUNCT TST PLETHYSMOGRAP |
1,159
|
1,159
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
1,008
|
1,009
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
910
|
917
|
|
80053
|
COMPREHEN METABOLIC PANEL |
899
|
899
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
J45.50 related to the following DRG Codes:
202-203
|
